As of today (2024-12-12), Insulet's share price is $273.47. Insulet's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $13.78. Hence, Insulet's Price to Tangible Book Ratio of today is 19.84.
The historical rank and industry rank for Insulet's Price-to-Tangible-Book or its related term are showing as below:
PODD'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 16.68 Med: 47.93 Max: 1492.61
Current: 19.85
During the past 13 years, Insulet's highest Price to Tangible Book Ratio was 1492.61. The lowest was 16.68. And the median was 47.93.
PODD's Price-to-Tangible-Book is ranked worse than 94.41% of 698
companies
in the Medical Devices & Instruments industry
Industry Median: 2.855
vs PODD: 19.85
A closely related ratio is called PB Ratio. As of today, Insulet's share price is $273.47. Insulet's Book Value per Sharefor the quarter that ended in Sep. 2024 was $15.94. Hence, Insulet's P/B Ratio of today is 17.16.
Insulet Price-to-Tangible-Book Historical Data
The historical data trend for Insulet's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Insulet's Price-to-Tangible-Book
For the Medical Devices subindustry, Insulet's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Insulet's Price-to-Tangible-Book falls into.
Insulet Price-to-Tangible-Book Calculation
Insulet's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Insulet Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Insulet's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PODD has been successfully added to your 